Literature DB >> 30204839

Neoadjuvant rectal score: run with the hare and hunt with the hounds.

F Sclafani1, E Kalaitzaki2, D Cunningham3, D Tait4, G Brown5, I Chau1.   

Abstract

Mesh：

Year:  2018        PMID： 30204839      PMCID： PMC6290879          DOI： 10.1093/annonc/mdy403

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Authors:  Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Maria Antonietta Gambacorta; Maria Cristina Barba; Marek Bebenek; Franck Bonnetain; Jean-Francois Bosset; Krzysztof Bujko; Luca Cionini; Jean-Pierre Gerard; Claus Rödel; Aldo Sainato; Rolf Sauer; Bruce D Minsky; Laurence Collette; Philippe Lambin
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

2.  Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score.

Authors:  Susana Roselló; Matteo Frasson; Eduardo García-Granero; Desamparados Roda; Esther Jordá; Samuel Navarro; Salvador Campos; Pedro Esclápez; Stephanie García-Botello; Blas Flor; Alejandro Espí; Carlotta Masciocchi; Vincenzo Valentini; Andrés Cervantes
Journal:  Clin Colorectal Cancer       Date:  2017-10-28       Impact factor: 4.481

3.  PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.

Authors:  F Sclafani; G Brown; D Cunningham; A Wotherspoon; D Tait; C Peckitt; J Evans; S Yu; L Sena Teixeira Mendes; J Tabernero; B Glimelius; A Cervantes; J Thomas; R Begum; J Oates; I Chau
Journal:  Ann Oncol       Date:  2016-05-23       Impact factor: 32.976

4.  Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.

Authors:  E Fokas; R Fietkau; A Hartmann; W Hohenberger; R Grützmann; M Ghadimi; T Liersch; P Ströbel; G G Grabenbauer; U Graeven; R-D Hofheinz; C-H Köhne; C Wittekind; R Sauer; M Kaufmann; T Hothorn; C Rödel
Journal:  Ann Oncol       Date:  2018-07-01       Impact factor: 32.976

Review 5.  Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials.

Authors:  Thomas J George; Carmen J Allegra; Greg Yothers
Journal:  Curr Colorectal Cancer Rep       Date:  2015
  5 in total
  1 in total

1.  Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer.

Authors:  Francesco Sclafani; Claudia Corrò; Thibaud Koessler
Journal:  Cancers (Basel)       Date:  2021-12-18       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.